277 related articles for article (PubMed ID: 37074530)
1. nNOS and Neurological, Neuropsychiatric Disorders: A 20-Year Story.
Zhu LJ; Li F; Zhu DY
Neurosci Bull; 2023 Sep; 39(9):1439-1453. PubMed ID: 37074530
[TBL] [Abstract][Full Text] [Related]
2. nNOS-mediated protein-protein interactions: promising targets for treating neurological and neuropsychiatric disorders.
Gu Y; Zhu D
J Biomed Res; 2020 Dec; 35(1):1-10. PubMed ID: 33402546
[TBL] [Abstract][Full Text] [Related]
3. Effects of propofol on expression of hippocampal neuronal nitric oxide synthase and carboxy-terminal PDZ ligand of neuronal nitric oxide synthase in stressed rats undergoing electroconvulsive shock.
Lv F; Shen YW; Peng LH; Li P; Luo J; Wei K; Li W; Chen J; Min S
J ECT; 2013 Dec; 29(4):297-302. PubMed ID: 24263275
[TBL] [Abstract][Full Text] [Related]
4. The Physiological Function of nNOS-Associated CAPON Proteins and the Roles of CAPON in Diseases.
Xie W; Xing N; Qu J; Liu D; Pang Q
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958792
[TBL] [Abstract][Full Text] [Related]
5. Changes in mRNA for CAPON and Dexras1 in adult rat following sciatic nerve transection.
Shen A; Chen M; Niu S; Sun L; Gao S; Shi S; Li X; Lv Q; Guo Z; Cheng C
J Chem Neuroanat; 2008 Jan; 35(1):85-93. PubMed ID: 17768032
[TBL] [Abstract][Full Text] [Related]
6. CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95.
Jaffrey SR; Snowman AM; Eliasson MJ; Cohen NA; Snyder SH
Neuron; 1998 Jan; 20(1):115-24. PubMed ID: 9459447
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal nuclear factor kappa B accounts for stress-induced anxiety behaviors via enhancing neuronal nitric oxide synthase (nNOS)-carboxy-terminal PDZ ligand of nNOS-Dexras1 coupling.
Zhu LJ; Ni HY; Chen R; Chang L; Shi HJ; Qiu D; Zhang Z; Wu DL; Jiang ZC; Xin HL; Zhou QG; Zhu DY
J Neurochem; 2018 Sep; 146(5):598-612. PubMed ID: 29858554
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CAPON and nitric oxide synthases in rat muscle regeneration after peripheral nerve injury.
Chen M; Cheng C; Yan M; Niu S; Gao S; Shi S; Liu H; Qin Y; Shen A
J Mol Neurosci; 2008; 34(1):89-100. PubMed ID: 18157660
[TBL] [Abstract][Full Text] [Related]
9. Prevention of the return of extinguished fear by disrupting the interaction of neuronal nitric oxide synthase with its carboxy-terminal PDZ ligand.
Qin C; Bian XL; Wu HY; Xian JY; Lin YH; Cai CY; Zhou Y; Kou XL; Li TY; Chang L; Luo CX; Zhu DY
Mol Psychiatry; 2021 Nov; 26(11):6506-6519. PubMed ID: 33931732
[TBL] [Abstract][Full Text] [Related]
10. Dissociating nNOS (Neuronal NO Synthase)-CAPON (Carboxy-Terminal Postsynaptic Density-95/Discs Large/Zona Occludens-1 Ligand of nNOS) Interaction Promotes Functional Recovery After Stroke via Enhanced Structural Neuroplasticity.
Ni HY; Song YX; Lin YH; Cao B; Wang DL; Zhang Y; Dong J; Liang HY; Xu K; Li TY; Chang L; Wu HY; Luo CX; Zhu DY
Stroke; 2019 Mar; 50(3):728-737. PubMed ID: 30727847
[TBL] [Abstract][Full Text] [Related]
11. Changes in mRNA for post-synaptic density-95 (PSD-95) and carboxy-terminal PDZ ligand of neuronal nitric oxide synthase following facial nerve transection.
Che YH; Tamatani M; Tohyama M
Brain Res Mol Brain Res; 2000 Mar; 76(2):325-35. PubMed ID: 10762708
[TBL] [Abstract][Full Text] [Related]
12. CAPON-nNOS coupling can serve as a target for developing new anxiolytics.
Zhu LJ; Li TY; Luo CX; Jiang N; Chang L; Lin YH; Zhou HH; Chen C; Zhang Y; Lu W; Gao LY; Ma Y; Zhou QG; Hu Q; Hu XL; Zhang J; Wu HY; Zhu DY
Nat Med; 2014 Sep; 20(9):1050-4. PubMed ID: 25129479
[TBL] [Abstract][Full Text] [Related]
13. Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON.
Jaffrey SR; Benfenati F; Snowman AM; Czernik AJ; Snyder SH
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3199-204. PubMed ID: 11867766
[TBL] [Abstract][Full Text] [Related]
14. Unexpected Heterodivalent Recruitment of NOS1AP to nNOS Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models.
Li LL; Melero-Fernandez de Mera RM; Chen J; Ba W; Kasri NN; Zhang M; Courtney MJ
J Neurosci; 2015 May; 35(19):7349-64. PubMed ID: 25972165
[TBL] [Abstract][Full Text] [Related]
15. Requirement of hippocampal DG nNOS-CAPON dissociation for the anxiolytic and antidepressant effects of fluoxetine.
Shi HJ; Wu DL; Chen R; Li N; Zhu LJ
Theranostics; 2022; 12(8):3656-3675. PubMed ID: 35664081
[No Abstract] [Full Text] [Related]
16. Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications.
Zhou L; Zhu DY
Nitric Oxide; 2009 Jun; 20(4):223-30. PubMed ID: 19298861
[TBL] [Abstract][Full Text] [Related]
17. Expression of CAPON after spinal cord injury in rats.
Cheng C; Li X; Gao S; Niu S; Chen M; Qin J; Guo Z; Zhao J; Shen A
J Mol Neurosci; 2008 Feb; 34(2):109-19. PubMed ID: 18074109
[TBL] [Abstract][Full Text] [Related]
18. nNOS-CAPON blockers produce anxiolytic effects by promoting synaptogenesis in chronic stress-induced animal models of anxiety.
Zhu LJ; Shi HJ; Chang L; Zhang CC; Si M; Li N; Zhu DY
Br J Pharmacol; 2020 Aug; 177(16):3674-3690. PubMed ID: 32343840
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effect of
Qin Y; Feng L; Fan X; Zheng L; Zhang Y; Chang L; Li T
ACS Chem Neurosci; 2021 Jan; 12(1):244-255. PubMed ID: 33356131
[TBL] [Abstract][Full Text] [Related]
20. Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity.
Chanrion B; Mannoury la Cour C; Bertaso F; Lerner-Natoli M; Freissmuth M; Millan MJ; Bockaert J; Marin P
Proc Natl Acad Sci U S A; 2007 May; 104(19):8119-24. PubMed ID: 17452640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
